Key result
Each one-point increase in ASA score prior to lumbar laminectomy and fusion was associated with a 1.93-day increase in hospital length of stay and a $7,474.62 increase in direct costs (P<0.001).
Why the study?
Spinal fusion carries high hospital costs, but literature directly addressing the influence of ASA status on cost and length of stay following lumbar laminectomy and fusion is limited.
Does ASA status predict increased cost and length of stay in patients undergoing lumbar laminectomy and fusion?
Cohort (n=1,849)
No
Does ASA status predict increased cost and length of stay in patients undergoing lumbar laminectomy and fusion?
Effect estimate: 1.93 days hospital LOS and $7474.62 direct cost increase per 1-point ASA increase
p-value: p=<0.001
Higher ASA status is a significant independent predictor of increased ICU length of stay, hospital length of stay, and direct costs following single-level lumbar laminectomy and fusion.
ASA class may predict higher costs/LOS after LLF; leaves open its value for risk adjustment in spine surgery.
STUDY DESIGN: Retrospective cohort study. OBJECTIVE: The objective of this study was to characterize the costs associated with American Society of Anesthesiologists (ASA) class, and to determine the extent to which ASA status is a predictor of increased cost and LOS following lumbar laminectomy and fusion (LLF). SUMMARY OF BACKGROUND DATA: Spinal fusion accounts for the highest hospital costs of any surgical procedure performed in the United States, and ASA (American Society of Anesthesiologists) status is a known risk factor for cost and length of stay (LOS) in the orthopedic literature. There is a paucity of literature that directly addresses the influence of ASA status on cost and LOS following LLF. METHODS: This is a retrospective cohort study of an institutional database of patients undergoing single-level LLF at an academic tertiary care facility from 2006 to 2016. Univariate comparisons were made using χ tests for categorical variables and t tests for continuous variables. Multivariate linear regression was utilized to estimate regression coefficients, and to determine whether ASA status is an independent risk factor for cost and LOS. RESULTS: A total of 1849 patients met inclusion criteria. For every one-point increase in ASA score, intensive care unit (ICU) LOS increased by 0.518 days (P < 0.001), and hospital length of stay increased by 1.93 days (P < 0.001). For every one-point increase in ASA score, direct cost increased by $7474.62 (P < 0.001). CONCLUSION: ASA status is a predictor of hospital LOS, ICU LOS, and direct cost. Consideration of the ways in which ASA status contributes to increased cost and prolonged LOS can allow for more accurate reimbursement adjustment and more precise targeting of efficiency and cost effectiveness initiatives. LEVEL OF EVIDENCE: 3.
No takes yet. Share an insight, caveat, or question.
Bronheim et al. (2019) conducted a cohort in Lumbar laminectomy and fusion (n=1,849). American Society of Anesthesiologists (ASA) status vs. Lower ASA score was evaluated on Intensive care unit (ICU) length of stay, hospital length of stay, and direct cost (1.93 days hospital LOS and $7474.62 direct cost increase per 1-point ASA increase, p=<0.001). Each one-point increase in ASA score prior to lumbar laminectomy and fusion was associated with a 1.93-day increase in hospital length of stay and a $7,474.62 increase in direct costs (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: